Published in J Virol on August 01, 1975
Escherichia coli mutant temperature sensitive for group I RNA bacteriophages. J Virol (1978) 0.82
Control of protein synthesis in Escherichia coli: control of bacteriophage Q beta coat protein synthesis after energy source shift-down. J Virol (1979) 0.79
Replication of RNA bacteriophages in the presence of rifamycin. J Virol (1978) 0.78
Streptomycin-resistant Escherichia coli mutant temperature sensitive for the production of Qbeta-infective particles. J Virol (1977) 0.77
Escherichia coli traD(Ts) mutant temperature sensitive for assembly of RNA bacteriophage MS2. J Virol (1981) 0.75
Purification and properties of the replicative intermediate of the RNA bacteriophage R17. Proc Natl Acad Sci U S A (1966) 7.55
Nucleotide sequence of the gene coding for the bacteriophage MS2 coat protein. Nature (1972) 5.05
REPLICATION OF VIRAL RNA, III. DOUBLE-STRANDED REPLICATIVE FORM OF MSW PHAGE RNA. Proc Natl Acad Sci U S A (1964) 4.24
Rifampicin sensitivity of the components of DNA-dependent RNA polymerase. Nature (1969) 3.50
Bacterial proteins required for replication of phage Q ribonucleic acid. Pruification and properties of host factor I, a ribonucleic acid-binding protein. J Biol Chem (1972) 3.45
Bacteriophage Q replicase contains the protein biosynthesis elongation factors EF Tu and EF Ts. Proc Natl Acad Sci U S A (1972) 2.88
Conservation of a viral RNA genome during replication and translation. Proc Natl Acad Sci U S A (1963) 2.61
Recognition of size and sequence by an RNA replicase. Proc Natl Acad Sci U S A (1965) 2.59
Comparison of two serologically distinct ribonucleic acid bacteriophages. I. Properties of the viral particles. J Bacteriol (1966) 2.52
Structure and function of phage RNA. Annu Rev Biochem (1973) 2.50
REPLICATION OF BACTERIOPHAGE RNA: STUDIES ON THE FATE OF PARENTAL RNA. J Mol Biol (1964) 2.48
Replication of the RNA of Bacteriophage f2. Science (1966) 2.48
Inhibition of DNA-dependent RNA synthesis by rifamycins. J Antibiot (Tokyo) (1968) 2.41
Subunit structure of Q-beta replicase. Nature (1970) 2.30
Characterization of the subunits of Q-beta replicase. Nature (1970) 2.24
Rifampicin inhibition of ribonucleic acid and protein synthesis in normal and ethylenediaminetetraacetic acid-treated Escherichia coli. J Bacteriol (1970) 2.19
Subunit I of G beta replicase and 30 S ribosomal protein S1 of Escherichia coli. Evidence for the identity of the two proteins. J Biol Chem (1974) 2.12
A rifampicin resistent rna-polymerase from E. coli altered in the beta-subunit. FEBS Lett (1969) 2.03
Reconstitution of Q replicase lacking subunit with protein-synthesis-interference factor i. Eur J Biochem (1972) 1.88
SEROLOGICAL CROSS REACTIONS AMONG THE RNA-CONTAINING COLIPHAGES. Virology (1965) 1.81
Isolation of a possible fourth group of RNA phage. Jpn J Microbiol (1968) 1.78
The biochemistry of RNA bacteriophage replication. Annu Rev Biochem (1970) 1.69
Grouping of RNA phages based on the template specificity of their RNA replicases. Proc Natl Acad Sci U S A (1971) 1.62
Resolution of two factors required in the Q-beta-RNA polymerase reaction. Nature (1968) 1.59
The kinetics of product appearance and template involvement in the in vitro replication of viral RNA. Proc Natl Acad Sci U S A (1967) 1.59
Function and structure in ribonucleic acid phage Q beta ribonucleic acid replicase. The roles of the different subunits in transcription of synthetic templates. J Biol Chem (1974) 1.54
Growth of bacteriophage f2 in E. coli treated with rifampicin. Proc Natl Acad Sci U S A (1968) 1.44
Extent of variation in three related bacteriophage RNA molecules. J Mol Biol (1972) 1.43
In vitro synthesis of phage RNA: the nature of the intermediates. Cold Spring Harb Symp Quant Biol (1968) 1.32
Rifamycins LXI: in vivo inhibition of RNA synthesis of rifamycins. Experientia (1968) 1.23
Structure of the poly(G) polymerase component of the bacteriophage f2 replicase. Proc Natl Acad Sci U S A (1971) 1.21
Host subunit of Q replicase is translation control factor i. Nat New Biol (1972) 1.17
Ribonucleic acid bacteriophage release: requirement for host-controlled protein synthesis. J Virol (1971) 1.13
Sequences of RNA fragments from the bacteriophage f2 coat protein cistron which differ from their R17 counterparts. Biochim Biophys Acta (1971) 1.13
Host interference with viral gene expression: mode of action of bacterial factor i. J Mol Biol (1974) 1.02
Effect of rifampicin on DNA-dependent RNA polymerase and on RNA phage growth. Cold Spring Harb Symp Quant Biol (1968) 1.02
Factor requirement of the bacteriophage f2 replicase. Nat New Biol (1973) 0.87
Inhibition of ribonucleic acid bacteriophage release from its host by rifampin. J Virol (1971) 0.87
Inhibition of RNA bacteriophage replication by rifampicin. J Mol Biol (1972) 0.84
Some studies of the infectious process with MS2 bacteriophage. Biochim Biophys Acta (1965) 0.84
Effect of rifampicin on the growth of RNA bacteriophage M12. FEBS Lett (1972) 0.82
Limited production of R17 ribonucleic acid phage in the presence of rifampin. Biochemistry (1972) 0.81
Effect of rifampin on the development of ribonucleic acid bacteriophage Q . J Virol (1971) 0.80
The conformation of ribonucleic acids in Escherichia coli ribosomes. Inferences from the mode of action of ribonuclease II. Biochem J (1967) 0.80
Induction of macrolide-lincosamide-streptogramin B resistance requires ribosomes able to bind inducer. Mol Gen Genet (1984) 1.97
DNA sequence and regulation of ermD, a macrolide-lincosamide-streptogramin B resistance element from Bacillus licheniformis. Mol Gen Genet (1984) 1.91
Semaphorins as mediators of neuronal apoptosis. J Neurochem (1999) 1.31
Ribonucleic acid bacteriophage release: requirement for host-controlled protein synthesis. J Virol (1971) 1.13
Evolutionary relationships of the Bacillus licheniformis macrolide-lincosamide-streptogramin B resistance elements. Mol Gen Genet (1984) 1.01
The requirement of nonsense suppression for the development of several phages. Mol Gen Genet (1979) 0.99
Sequence homologies between ribosomal and phage RNAs: a proposed molecular basis for RNA phage parasitism. J Mol Biol (1976) 0.96
Heparin and the atherosclerotic process. Pharmacol Rev (1984) 0.90
Inhibition of ribonucleic acid bacteriophage release from its host by rifampin. J Virol (1971) 0.87
Inhibition of RNA bacteriophage replication by rifampicin. J Mol Biol (1972) 0.84
Studies with the Chandler rotating loop. Evidence that thrombin generation is responsible for the formation of the artificial in vitro thrombi. Thromb Diath Haemorrh (1969) 0.83
Stabilization and breakdown of Escherichia coli messenger ribonucleic acid in the presence of chloramphenicol. Biochemistry (1972) 0.81
Regulation of the escherichia coli tryptophan operon by readthrough of UGA termination codons. Biochem Biophys Res Commun (1981) 0.81
Mechanisms involved in the reduction of serum triglycerides in man upon adding unsaturated fats to the normal diet. Metabolism (1966) 0.80
Probable physiologic functions of heparin. Fed Proc (1977) 0.80
The preparation and characterization of ribonucleic acid obtained by direct phenol extraction of intact cells of Escherichia coli from low ionic environment. Biochem Biophys Res Commun (1966) 0.80
The conformation of ribonucleic acids in Escherichia coli ribosomes. Inferences from the mode of action of ribonuclease II. Biochem J (1967) 0.80
Q beta-defective particles produced in a streptomycin-resistant Escherichia coli mutant. J Virol (1979) 0.79
Heparin and atherosclerosis. A review of old and recent findings. Am Heart J (1980) 0.78
Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens. Arch Toxicol (2001) 0.78
Streptomycin-resistant Escherichia coli mutant temperature sensitive for the production of Qbeta-infective particles. J Virol (1977) 0.77
Serum lipemia: an overlooked cause of tissue hypoxia. Cardiology (1983) 0.76
Studies on the fate of parental bacteriophage RNA in the host. J Mol Biol (1970) 0.75
Messenger RNA from normal and T 4 phage-infected Escherichia coli: isolation and size distribution. Biochim Biophys Acta (1972) 0.75
The flowing clotting time (thrombus formation time) a sensitive test of hypercoagulability. Thromb Diath Haemorrh (1969) 0.75
Heparin: physiology and pathobiology. Pathobiol Annu (1978) 0.75
Postabsorptive serum triglyceride levels in man after the addition of highly unsaturated fish oils to the diet. Metabolism (1966) 0.75
Heparin, heparin fractions, and the atherosclerotic process. Semin Thromb Hemost (1985) 0.75
Heparin and atherosclerosis. Monogr Atheroscler (1978) 0.75
Lipid disorders and heart-disease. Lancet (1970) 0.75
Heparin and vascular endothelium. Vasc Surg (1978) 0.75
The effect of cigarette smoking on various clotting time tests. Vasc Dis (1968) 0.75
Ultra-low-dose intravenous heparin. Lancet (1980) 0.75
The clinical use of heparin. Curr Ther Res Clin Exp (1975) 0.75
Cigarette smoking and thrombotic coagulation of human blood. Further in vitro studies. Arch Environ Health (1967) 0.75
Studies of optimal conditions for the measurement of circulating endogenous lipoprotein lipase activity. J Atheroscler Res (1970) 0.75
Heparin and atherosclerosis. Adv Lipid Res (1983) 0.75
The effect of a heparin antagonist on fasting serum triglycerides in man. J Atheroscler Res (1966) 0.75